Companies · Other Health Care

AdvocateMH Inc.New on the radar

BOSTON · Other Health Care

Diligence memoA one-page analyst read on AdvocateMH Inc. — recommendation, valuation, rhythm, risks.
$6.2M
Total raised · real
1
Rounds
Latest step-up
Top 33%
Sector rank · raised
Series A
Latest stage · inferred · Wed Feb 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

AdvocateMH Inc. looks fair against its niche peers and is active on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 1.46× the median modeled value of Series A Other Health Care companies in 2025–2027 (83 peers) — value vs value, same stage and era.
  • Within the normal band (146% of peer median) for its niche.
Active
  • Last raise 16 mo ago; this sector typically re-raises about every 14 months.
  • Raising on or ahead of the sector's normal rhythm.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

AdvocateMH Inc. is one of 5376 Other Health Care companies tracked from BOSTON. By capital raised it ranks mid-pack (ahead of 68% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
9
Investors (latest)
2025
Year incorporated
2025-02-26
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$13M$25M$38M$50MSeries A · 2025-02-26 Raised $6.2M (real) Modeled valuation $24M (est)$6.2M$24MSeries A2025

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$6.2M · 2025

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 33%.

Modeled valuation trajectory
$23.8M
Base estimate est.
$8.0M
Conservative case
$44.1M
Upside case
$28.4M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
1.3 yr
Elapsed time used
1.3 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
Avg between rounds
Capital velocity
1.3 yr
On record since
2025
First round
New
First-time filer
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 2.6× above median
This company$6.2M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 1.1× above median
This company$6.2M
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 1.1× above median
This company$23.8M
Sector median$22.1M

Raised more than 68% of sector peers (real $). Modeled value above 52% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #25 of 83.

This companyCohort peer
$10.0M$100.0M$1.0M$10.0M$100.0MCapital raised (log)HelloJoy, Inc. · Series A Raised $26.3M · modeled $55.0M (est)Maui Imaging, Inc. · Series A Raised $29.9M · modeled $51.0M (est)Celltrio, Inc. · Series A Raised $15.0M · modeled $50.8M (est)Medmo, Inc. · Series A Raised $31.7M · modeled $44.7M (est)Vertical Orthopaedics, Inc. · Series A Raised $16.7M · modeled $44.0M (est)AbriCare, Inc. · Series A Raised $15.0M · modeled $39.1M (est)WP Stillwater, LLC · Series A Raised $14.3M · modeled $38.1M (est)Sylke, Inc. · Series A Raised $15.9M · modeled $37.6M (est)Iridex Corp · Series A Raised $10.0M · modeled $37.2M (est)2GHealth Inc. · Series A Raised $17.5M · modeled $35.6M (est)Okc Alf 4, Llc · Series A Raised $8.9M · modeled $34.5M (est)HC Jones, Inc. · Series A Raised $14.1M · modeled $33.4M (est)AdvocateMH Inc. (this company) Raised $6.2M · modeled $23.8M (est)AdvocateMH Inc.
CompanyStageRaised · realValue · estvs peer med.
HelloJoy, Inc.Series A$26.3M$55.0M3.37×
Maui Imaging, Inc.Series A$29.9M$51.0M3.12×
Celltrio, Inc.Series A$15.0M$50.8M3.11×
Medmo, Inc.Series A$31.7M$44.7M2.74×
Vertical Orthopaedics, Inc.Series A$16.7M$44.0M2.69×
AbriCare, Inc.Series A$15.0M$39.1M2.39×
WP Stillwater, LLCSeries A$14.3M$38.1M2.33×
Sylke, Inc.Series A$15.9M$37.6M2.30×
Iridex CorpSeries A$10.0M$37.2M2.28×
2GHealth Inc.Series A$17.5M$35.6M2.18×
Okc Alf 4, LlcSeries A$8.9M$34.5M2.11×
HC Jones, Inc.Series A$14.1M$33.4M2.04×
AdvocateMH Inc. this companySeries A$6.2M$23.8M1.46×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$6.2M2025-02-26$28.4M$23.8M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$6.2M2025-02-26
    • First recorded raise — entered as Series A.
    • 9 investors on this round.
Intelligence
Modeled next raise
$10.0M
Modeled next size est.range $6.5M$16.0M
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
David Mou2025-02
Thomas Insel2025-02
Registry & provenance

AdvocateMH Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
2059980
SEC CIK
2025
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Rebel Medicine IncOther Health CareSeries A$6.1M$23.5Msame sector · same stage
Jellyfish Health, LLCOther Health CareSeries A$6.0M$25.9Msame sector · same stage
StrokeDx, Inc.Other Health CareSeries A$6.0M$21.6Msame sector · same stage
Bexa Inc.Other Health CareSeries A$6.0M$24.5Msame sector · same stage
Animerra, Inc.Other Health CareSeries A$6.5M$25.7Msame sector · same stage
Nanox Imaging plc.Other Health CareSeries A$6.7M$22.3Msame sector · same stage
Twinlab Consolidated Holdings, Inc.Other Health CareSeries A$6.7M$20.2Msame sector · same stage
Voyager Biomedical, Inc.Other Health CareSeries A$6.8M$21.6Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Homh, Inc.Other Health CarePre-Seed$11.6M88%
HomeCare Advocacy Network, Inc.Other Health CarePre-Seed$8.9M86%
Advocate Sherman Ambulatory Surgery Center, LLCOther Health CareSeed$52.2M85%
MCH Ventures, Inc.Other Health CareSeed$7.1M84%
MHDG Independent Practice Association, Inc.Other Health CarePre-Seed$4.3M84%
ALM Ortho IncOther Health CarePre-Seed$578K84%
InspireMD, Inc.Other Health CareSeries C$248.1M84%
EvidenceCare, Inc.Other Health CareSeries B$50.7M84%
Frequently asked
How much funding has AdvocateMH Inc. raised?
AdvocateMH Inc. has raised approximately $6.2M in disclosed capital across 1 recorded financing round, aggregated from public filings.
What is AdvocateMH Inc.'s estimated valuation?
Provath's modeled valuation for AdvocateMH Inc. is approximately $23.8M (modeled range $8.0M–$44.1M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is AdvocateMH Inc. at?
AdvocateMH Inc.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Wed Feb 26.
What does AdvocateMH Inc. do and where is it based?
AdvocateMH Inc. operates in the Other Health Care sector, based in BOSTON.
Explore related

See where AdvocateMH Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at AdvocateMH Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.